Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atara Biotherap (NQ: ATRA )

16.78 USD +0.17 (+1.02%)
Official Closing Price Updated: 4:22 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 803,600
Open 16.72
Bid (Size) 15.16 (2)
Ask (Size) 18.14 (2)
Prev. Close 16.61
Today's Range 16.29 - 17.15
52wk Range 4.520 - 28.20
Shares Outstanding 43,949,486
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021
Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases... 
From Business Wire News Releases
Atara Biotherapeutics Presents Key Data for Advancing the Development of Tab-cel® and ATA188 at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases... 
From Business Wire News Releases

Performance

YTD
-14.56%
-14.56%
1 Month
-10.65%
-10.65%
3 Month
-27.89%
-27.89%
6 Month
+23.66%
+23.66%
1 Year
+46.17%
+46.17%

More News

Read More
Atara Biotherapeutics to Present Data at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience
From Business Wire News Releases
Atara Biotherapeutics Will Present Recent Advancements and Key Upcoming Milestones at the 39th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
Atara Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
InvestorNewsBreaks – Atara Biotherapeutics Inc. (NASDAQ: ATRA) Secures $175M in Underwritten Public Offering
From InvestorBrandNetwork
Atara Biotherapeutics Provides Regulatory Update for Tab-Cel® for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease
From Business Wire News Releases
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tags RGLS Movers ATRA
From Benzinga
Atara Biotherapeutics Announces Pricing of $175.0 Million Public Offering
From Business Wire News Releases
Thinking about buying stock in Clovis Oncology, Ashford Hospitality Trust, Atara Biotherapeutics, Sorrento Therapeutics, or Vertex Energy?
From PR Newswire
Atara Biotherapeutics Scores Relative Strength Rating Upgrade; Hits Key Threshold
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.